Exact Sciences
$58.11
24H
Market Cap
Volume
Supply
Price Chart
About Exact Sciences - EXAS
Exact Sciences Corporation is an American molecular diagnostics company that develops and markets tests for the detection of colorectal cancer and other diseases of the digestive system, with its flagship product being the non-invasive at-home Cologuard test for colorectal cancer screening. The company aims to provide accurate, minimally invasive screening and diagnostic tests to aid in early detection and treatment of disease.
What are Exact Sciences's core values and mission statement?
Exact Sciences Corporation's mission is to deliver accurate, non-invasive cancer screening and diagnostic products to improve patient outcomes. Their core values are focused on innovation, quality, and teamwork to guide their work in early cancer detection and treatment.
Who founded Exact Sciences and when?
Exact Sciences Corporation was founded by Stanley Lapidus, who launched the company in 1995.
Who leads Exact Sciences?
As of my last update, Kevin Conroy holds the position of Chairman and CEO of Exact Sciences Corporation.
Where is Exact Sciences located, and what is its base country?
Exact Sciences Corporation is headquartered in Madison, Wisconsin, and its base country is the United States.
On which exchanges is Exact Sciences traded?
Exact Sciences Corporation is traded on the Nasdaq Stock Market under the ticker symbol EXAS.
Historical data
Exact Sciences (EXAS) Price Live Data
The live price of Exact Sciences (EXAS) is $58.11, with a trading volume of 484,879 in the last 24 hours. Wrapstocks updates the EXAS price in real-time. Exact Sciences is down -1.39% in the last 24 hours. The company has a live market cap of $10,754,766,848.00 and a supply of 185,076,008 EXAS stocks.
Exact Sciences (EXAS) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 7 hours and 46 minutes.
